MECHELLI, ROSELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.348
AS - Asia 1.571
EU - Europa 462
SA - Sud America 146
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 38
OC - Oceania 4
Totale 4.687
Nazione #
US - Stati Uniti d'America 2.112
SG - Singapore 424
TR - Turchia 413
CN - Cina 393
IT - Italia 288
CA - Canada 204
VN - Vietnam 123
BR - Brasile 104
BD - Bangladesh 74
DE - Germania 47
HK - Hong Kong 43
EU - Europa 36
FI - Finlandia 24
IN - India 23
IR - Iran 23
AR - Argentina 22
GB - Regno Unito 19
IE - Irlanda 18
MX - Messico 12
EG - Egitto 11
ID - Indonesia 11
IL - Israele 9
PL - Polonia 9
SC - Seychelles 9
ZA - Sudafrica 9
NL - Olanda 7
UA - Ucraina 7
FR - Francia 6
PK - Pakistan 6
SE - Svezia 6
VE - Venezuela 6
ES - Italia 5
IQ - Iraq 5
PH - Filippine 5
RS - Serbia 5
CO - Colombia 4
CR - Costa Rica 4
LT - Lituania 4
MA - Marocco 4
OM - Oman 4
RU - Federazione Russa 4
EC - Ecuador 3
RO - Romania 3
SA - Arabia Saudita 3
UY - Uruguay 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BS - Bahamas 2
GT - Guatemala 2
JM - Giamaica 2
MK - Macedonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AT - Austria 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
VI - Stati Uniti Isole Vergini 1
Totale 4.607
Città #
San Mateo 361
Kocaeli 352
San Jose 220
Ashburn 197
Toronto 182
Rome 179
Council Bluffs 151
Dallas 142
Beijing 133
Singapore 129
Wilmington 99
Santa Clara 90
Phoenix 78
Houston 76
Lawrence 65
Princeton 65
Hanoi 40
Ho Chi Minh City 37
Hong Kong 35
Los Angeles 34
Fairfield 31
Shanghai 27
Frankfurt am Main 23
New York 19
Woodbridge 19
Guangzhou 17
Ann Arbor 16
Tehran 15
Turku 14
Cambridge 13
Chandler 13
Milan 12
Seattle 12
Montreal 11
Munich 11
Helsinki 10
Warsaw 9
Buffalo 8
Chicago 8
Shenzhen 8
Atlanta 7
Jiaxing 7
Redwood City 7
São Paulo 7
Dublin 6
West Jordan 6
Belgrade 5
Biên Hòa 5
Cairo 5
Chennai 5
Florence 5
Islamabad 5
Manchester 5
Naples 5
Netanya 5
San Francisco 5
The Dalles 5
Varedo 5
Xi'an 5
Belo Horizonte 4
Brooklyn 4
Columbus 4
Curitiba 4
Da Nang 4
Istanbul 4
Johannesburg 4
Kyiv 4
Las Vegas 4
Muscat 4
Turin 4
Abbeville 3
Andover 3
Ankara 3
Bologna 3
Charlotte 3
Haiphong 3
Livermore 3
Makati City 3
Mexico City 3
Montevideo 3
Mumbai 3
Nanjing 3
New Delhi 3
Newark 3
Pesaro 3
Quanzhou 3
Queens 3
Rockville 3
San José 3
Shrewsbury 3
Tashkent 3
Venice 3
Wuhan 3
Wuxi 3
Anaheim 2
Boston 2
Brescia 2
Buenos Aires 2
Bắc Ninh 2
Cape Town 2
Totale 3.194
Nome #
Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins 191
Vaccines in multiple sclerosis. The experience of BCG vaccination 112
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis 99
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis 92
Varianti genotipiche del virus di Epstein Barr e loro usi come possibili predittori di rischio, biomarcatori e target terapeutici nella sclerosi multipla 91
Characterization of Epstein-Barr virus genotypes in multiple sclerosis 86
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects 78
Transciptome of B lymphocytes in multiple sclerosis 78
Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 78
Acetylated nucleosome assembly on telomeric DNAs 76
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets 74
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 73
Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood 72
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis 72
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study 71
Increased CD8(+) T cell responses to apoptotic T cell-associated antigens in multiple sclerosis 71
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients 71
IFN-β and multiple sclerosis: From etiology to therapy and back 71
Multiple sclerosis etiology: beyond genes and environment 70
Epigenetic reprogramming in peripheral mononuclear cells from multiple sclerosis patients 70
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis 69
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 69
CD28 individual signals amplify pro-inflammatory cytokine production in relapse-remitting multiple sclerosis T lymphocytes 69
Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis 69
A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors 68
IFN-beta therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients 67
Epstein-Barr virus genetic variants are associated with multiple sclerosis 66
Chemical Elements and Oxidative Status in Neuroinflammation 66
Superstuctural features of telomeric chromatin 66
Association between vaccines and neuroinflammation. time, risks, and benefits 66
Telomeric nucleosomes are intrinsically mobile 66
Multiple sclerosis: pharmacogenomics and personalised drug treatment 66
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: the Case of Edaravone 65
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients 65
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy 64
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 64
arsenical c-glucoside derivatives with promising antitumor activity 63
Evidence for detrimental cross interactions between reactive oxygen and nitrogen species in Leber's hereditary optic neuropathy cells 63
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells 63
Geographic population structure in Epstein-Barr Virus revealed by comparative genomics 62
Interferon-b therapy targets memory B cells of multiple sclerosis patients: investigation of the mechanism 62
Organization of Telomeric Nucleosomes: Atomic Force Microscopy Imaging and Theoretical Modeling 61
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes 61
Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins 60
Effects of Interferon-beta therapy on the expression of Epstein-Barr virus transcripts in PBMC of patients with Relapsing-Remitting Multiple Sclerosis 60
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease 59
Large scale agent-based modeling of the humoral and cellular immune response 59
CD161(high) CD8(+)T cells bear pathogenetic potential in multiple sclerosis 59
IFN-β and Multiple Sclerosis. from etiology to therapy and back 58
The role of sequence dependent DNA superstructural features in chromatin organization 58
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases 58
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology 58
Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study 57
Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis 56
Intestinal Permeabiliy in Relapsing-Remitting Multiple Sclerosis 56
The response to Toll-like receptor stimulation is impaired in plasmacytoid dendritic cells of multiple sclerosis patients undergoing interferon-b therapy 55
Increased circulating levels of vitamin D binding protein in MS patients 54
GENOMIC AND PROTEOMIC ANALYSIS OF CD8+ TCELL SUBSETS IN MONOZYGOTIC TWIN PAIRS DISCORDING FOR MULTIPLE SCLEROSIS 54
Telomeric nucleosomes organization: atomic force microscopy imaging and theoretical modeling 54
Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain 53
PS1-009. TLR responsiveness of B cells is modulated in patients with multiple sclerosis following IFN-β therapy 53
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 51
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study 50
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome 45
Genome-Wide Multiple Sclerosis Association Data and Coagulation 45
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? 45
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach 40
Viruses and neuroinflammation in multiple sclerosis 38
Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis 35
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy 34
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Dimethylfumarate 32
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases 32
A disease-specific convergence of host and Epstein–Barr virus genetics in multiple sclerosis 15
Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy 8
Totale 4.687
Categoria #
all - tutte 42.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022284 0 0 0 2 4 0 92 66 7 105 6 2
2022/2023187 144 1 6 3 4 6 3 7 1 3 6 3
2023/2024160 4 1 1 4 5 33 4 4 0 19 2 83
2024/2025680 33 92 87 15 44 89 67 52 82 7 22 90
2025/20261.626 134 131 153 137 118 198 230 88 114 163 95 65
2026/2027565 22 204 243 96 0 0 0 0 0 0 0 0
Totale 4.687